Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses

Vaccine

Volumn 24, Issue 17, 2006, Pages 3522-3529

  Goter Robinson, Carol ^a   Derrick, Steven C ^a   Yang, Amy Li ^a   Jeon, Bo Young ^a   Morris, Sheldon L ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

BCG; DNA Vaccines; Interferon ; Tuberculosis

Indexed keywords

BCG VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 12; MESSENGER RNA; RANTES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFECT; IMMUNE RESPONSE; IMMUNIZATION; LONG TERM CARE; LUNG ALVEOLUS CELL; LUNG LAVAGE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

AIR MICROBIOLOGY; ANIMALS; BCG VACCINE; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; IMMUNIZATION, SECONDARY; INTERFERON TYPE II; LUNG; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; RNA, MESSENGER; TUBERCULOSIS; VACCINATION; VACCINES, DNA;

EID: 33645237451     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.02.005     Document Type: Article

References (27)

1. E.I. Corbett, C.J. Watt, N. Walker, D. Maher, B.G. Williams, and Raviglone The growing burden of tuberculosis: global trends and interactions with the HIV epidemic Arch Intern Med 163 2003 1009 1021
2. H. McShane Co-infection of HIV and TB: double trouble Int J STD AIDS 16 2005 95 101
3. World Health Organization, Tuberculosis - Fact Sheet 104; 2004. http://www.who.int/mediacentre/factsheets.
4. S.H.E. Kaufmann, and A.J. McMichael Annulling a dangerous liason: vaccination strategies against AIDS and tuberculosis Nat Med 11 2005 533 543
5. A. Zumla, P. Malon, J. Henderson, and J. Grange Impact of HIV on tuberculosis Postgrad Med J 76 2000 259 268
6. C. Dye, M.A. Espinal, C.J. Watt, C. Mbianga, and B.G. Williams Worldwide incidence of multidrug-resistant tuberculosis J Infect Dis 185 2002 1197 1202
7. G.A. Colditz, T.F. Brewer, C.S. Berkey, M.E. Wilson, V. Burdick, and H.V. Fineberg Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature JAMA 271 1994 698 702
8. J.J. Ellner, C. Hirsch, and C. Whalen Correlates of protective immunity to Mycobacterium tuberculosis in humans Clin Infect Dis 30 Suppl. 3 2000 S279 S282
9. J.L. Flynn, and J. Chan Immunology of tuberculosis Ann Rev Immunol 19 2001 93 129
10. A. Chackerian, T.V. Perera, and S.M. Behar Gamma interferon producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis Infect Immun 69 2001 2666 2674
11. A. Caruso, N. Serbina, E. Klein, K. Triebold, B.R. Bloom, and J.L. Flynn Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis J Immunol 1999 5407 5416
12. J. Turner, and I.M. Orme The expression of early resistance to an infection with Mycobacterium tuberculosis by old mice is dependent on IFN type II (IFN-g) but not IFN type I Mech Ageing Dev 125 2004 1 9
13. A.T. Kamath, N.L. Groat, A.G. Bean, and W.J. Britton Protective effect of DNA immunization against mycobacterial infection is associated with early emergence of interferon-gamma (IFN-gamma)-secreting lymphocytes Clin Exp Immunol 120 2000 476 482
14. G. Delogu, A. Li, C. Repique, F. Collins, and S. Morris DNA vaccine combinations expressing either tissue plasminogen activator signal sequences or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis Infect Immun 70 2002 292 302
15. S.D. Derrick, A. Yang, and S.L. Morris A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity Vaccine 23 2004 780 788
16. Z. Li, A. Howard, C. Kelley, G. Delogu, F. Collins, and S. Morris Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences Infect Immun 67 1999 4780 4786
17. S. Morris, C. Kelley, A. Howard, Z. Li, and F. Collins The immunogenicity of single and combination vaccines against tuberculosis Vaccine 18 2000 2155 2163
18. G.F. Black, R.F. Weir, S. Floyd, L. Bliss, D.K. Warndorff, and A.C. Crampin BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomized controlled studies Lancet 359 2002 1393 1401
19. C.S. Hirsch, Z. Toossi, C. Othieno, J.L. Johnson, S.K. Schwander, and S. Robertson Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy J Infect Dis 180 1999 2069 2073
20. E.K. Jo, H.J. Kim, J.H. Lim, D. Min, Y. Song, and T.H. Palk Dysregulated production of interferon-gamma, interleukin-4, and interleukin-6 in early tuberculosis patients in response to antigen 85B of Mycobacterium tuberculosis Scand J Immunol 51 2000 209 217
21. Horst Ibelgrafts' COPE, Cytokine online pathfinder encyclopaedia. Rantes; 2004. http://www.copewithcytokines.de/cope.
22. I.M. Orme, and F.M. Collins Aerogenic vaccination of mice with Mycobacterium bovis BCG Tubercle 67 1986 133 140
23. A. Cooper, J.E. Callahan, J.P. Griffin, A.D. Roberts, and I.M. Orme Old mice are able to control low-dose aerogenic infections with Mycobacterium tuberculosis Infect Immun 63 1995 3259 3265
24. J. Turner, A.A. Frank, and I.M. Orme Old mice express a transient early resistance to pulmonary tuberculosis that is mediated by CD8 T cells Infect Immun 70 2002 4628 4637
25. L.A.H. van Pinxteren, J.P. Cassidy, B. Smedegaard, E.M. Agger, and P. Andersen Control of latent Mycobacterium tuberculosis is dependent on CD8 T cells Eur J Immunol 30 2000 3689 3698
26. E.R. Rhoades, A.A. Frank, and I.M. Orme Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis Tubercle Lung Dis 78 1997 57 66
27. A.M. Dannenberg, and F.M. Collins Progressive tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products Tuberculosis 81 2001 229 242